Storage at -3°C for 24 h alters the immunogenicity of pertussis vaccines

被引:32
作者
Boros, CA
Hanlon, M
Gold, MS
Roberton, DM
机构
[1] Univ Adelaide, Womens & Childrens Hosp, Dept Paediat, Adelaide, SA 5006, Australia
[2] New Childrens Hosp, Dept Immunol & Infect Dis, Parramatta, NSW 2124, Australia
关键词
vaccine; storage; immunogenicity;
D O I
10.1016/S0264-410X(01)00063-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunogenicity of pertussis antigens in an acellular and a whole-cell triple antigen vaccine used for childhood immunisation was assessed in murine models after storage of vaccines below 0 degreesC. Swiss outbred and Balb/c mice received DTPa or DTPw vaccine or placebo. Vaccines were stored at 2-8 degreesC (ideal), or at - 3 degreesC for 24 h. Pre and post immunisation IgG responses to pertussis toxin (PT), filamentous haemagglutinin (FHA) and pertactin (PRN) were measured using enzyme immunoassays (EIA). In Balb/c mice, responses to pertactin after receiving adversely stored DTPa were significantly reduced (P = 0.005, difference in GMCs 145.9% [24.6-385.4%]). A reduction in GMC to pertactin was also seen in response to adversely stored DTPw (P = 0.190, 224.1% [83.8-599.2%]). Outbred mice receiving adversely stored DTPa had lower IgG antibody responses to FHA than those receiving correctly stored vaccine (P = 0.002, 522.2% [26.1-2155.6%]). Outbred mice also had a significantly lower response to FHA after administration of DTPw (P = 0.009, 14.0% [3.8-51.9%]). Responses to DTPa in both strains generally were greater than those to DTPw. Storage of pertussis vaccines below 0 degreesC appears to alter the immunogenicity of PRN and FHA. Further study is required to determine the effects of such storage on vaccine protective efficacy. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3537 / 3542
页数:6
相关论文
共 44 条
  • [1] COMPARISON OF A 3-COMPONENT ACELLULAR PERTUSSIS-VACCINE WITH A WHOLE-CELL PERTUSSIS-VACCINE IN 4-YEAR-OLD THROUGH 6-YEAR-OLD CHILDREN
    ANNUNZIATO, PW
    ROTHSTEIN, EP
    BERNSTEIN, HH
    BLATTER, MM
    REISINGER, KS
    PICHICHERO, ME
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1994, 148 (05): : 503 - 507
  • [2] Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: Variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0
    Barnard, A
    Mahon, BP
    Watkins, J
    Redhead, K
    Mills, KHG
    [J]. IMMUNOLOGY, 1996, 87 (03) : 372 - 380
  • [3] BINKIN NJ, 1992, PEDIATR INFECT DIS J, V11, P653
  • [4] BISHAI DM, 1992, PEDIATRICS, V89, P193
  • [5] COMPARISON OF ACELLULAR AND WHOLE-CELL PERTUSSIS-COMPONENT DIPHTHERIA-TETANUS-PERTUSSIS VACCINES IN INFANTS
    BLUMBERG, DA
    MINK, CM
    CHERRY, JD
    JOHNSON, C
    GARBER, R
    PLOTKIN, SA
    WATSON, B
    BALLANCO, GA
    DAUM, RS
    SULLIVAN, B
    TOWNSEND, TR
    BRAYTON, J
    GOOCH, WM
    NELSON, DB
    CONGENI, BL
    PROBER, CG
    HACKELL, JG
    DEKKER, CL
    CHRISTENSON, PD
    [J]. JOURNAL OF PEDIATRICS, 1991, 119 (02) : 194 - 204
  • [6] COMPARISON OF AN ACELLULAR PERTUSSIS-COMPONENT DIPHTHERIA-TETANUS-PERTUSSIS (DTP) VACCINE WITH A WHOLE-CELL PERTUSSIS-COMPONENT DTP VACCINE IN 17-MONTH-OLD TO 24-MONTH-OLD CHILDREN, WITH MEASUREMENT OF 69-KILODALTON OUTER-MEMBRANE PROTEIN ANTIBODY
    BLUMBERG, DA
    MINK, CM
    CHERRY, JD
    REISINGER, KS
    BLATTER, MM
    CONGENI, BL
    DEKKER, CL
    STOUT, MG
    MEZZATESTA, JR
    SCOTT, JV
    CHRISTENSON, PD
    [J]. JOURNAL OF PEDIATRICS, 1990, 117 (01) : 46 - 51
  • [7] CASTO DT, 1991, PEDIATRICS, V87, P108
  • [8] A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
    Cherry, JD
    Gornbein, J
    Heininger, U
    Stehr, K
    [J]. VACCINE, 1998, 16 (20) : 1901 - 1906
  • [9] GENETIC-VARIATION WITHIN AND BETWEEN STRAINS OF OUTBRED SWISS MICE
    CUI, SL
    CHESSON, C
    HOPE, R
    [J]. LABORATORY ANIMALS, 1993, 27 (02) : 116 - 123
  • [10] Dimayuga R, 1995, Can Commun Dis Rep, V21, P101